Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China

BACKGROUND: Real-life studies evaluating the long-term efficacy of guselkumab in moderate-to-severe psoriasis in China are limited and not available. METHODS: In this real-life study, we retrospectively examined a total of 27 patients with moderate-to-severe psoriasis treated with guselkumab [100 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, hu, Kun, Li, Xingyu, Hu, Jingjin, Tan, Minjia, Zhang, Mi, Kuang, Yehong, Lv, Chengzhi, Chen, Junchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884724/
https://www.ncbi.nlm.nih.gov/pubmed/36481840
http://dx.doi.org/10.1007/s13555-022-00869-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884724/
https://www.ncbi.nlm.nih.gov/pubmed/36481840
http://dx.doi.org/10.1007/s13555-022-00869-w

Ejemplares similares